Log in to save to my catalogue

Repurposing infectious disease vaccines for intratumoral immunotherapy

Repurposing infectious disease vaccines for intratumoral immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e52ee756c30c4f159c2cd972a6359ef7

Repurposing infectious disease vaccines for intratumoral immunotherapy

About this item

Full title

Repurposing infectious disease vaccines for intratumoral immunotherapy

Publisher

England: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2020-02, Vol.8 (1), p.e000443

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

Intratumoral delivery of viruses and virus-associated molecular patterns can achieve antitumor effects that are largely mediated by the elicitation or potentiation of immune responses against the malignancy. Attenuated vaccines are approved and marketed as good manufactiring practice (GMP)-manufactured agents whose administration might be able to i...

Alternative Titles

Full title

Repurposing infectious disease vaccines for intratumoral immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e52ee756c30c4f159c2cd972a6359ef7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e52ee756c30c4f159c2cd972a6359ef7

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1136/jitc-2019-000443

How to access this item